Yi, Zongbi
Ma, Fei http://orcid.org/0000-0001-9432-1902
Liu, Binliang
Guan, Xiuwen
Li, Lixi
Li, Chunxiao
Qian, Haili
Xu, Binghe
Funding for this research was provided by:
National Natural Science Foundation of China (81472453)
Major Project of Beijing Municipal Science and Technology Commission (D161100000816004)
CAMS Initiative for Innovative Medicine (CAMS-12M-1-010, 2017-I2M-3-004)
Article History
Received: 27 February 2018
Accepted: 1 May 2019
First Online: 14 May 2019
Ethics approval and consent to participate
: The study was reviewed and approved by the ethics committee at the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College. The collection and sequencing of peripheral blood samples of patients who consented to participate in ctDNA analysis were approved by the ethics committee (ref: 16–038/1117). Written informed consent was obtained from all patients who participated in the ctDNA analysis. Due to the retrospective approach of this study, the need for informed consent from patients who did not participate int he ctDNA analysis was waived by the ethics committees.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.